{
    "title": "MY BIZ: Pharma firms face U.S. wrath over manufacturing standards",
    "url": "https://www.dailymail.co.uk/indiahome/indianews/article-2458343/Pharma-firms-face-U-S-wrath-manufacturing-standards-set-brought-scratch.html",
    "date": "2013-10-13",
    "keywords": [
        "manufacturing",
        "drug",
        "usfda",
        "cent",
        "share",
        "warning",
        "plant",
        "mohali",
        "october",
        "analysis",
        "june",
        "ranbaxy",
        "inspection",
        "companys",
        "letter",
        "biz",
        "pharma",
        "arun",
        "gmt",
        "email",
        "view",
        "home",
        "watchdog",
        "slack",
        "growth",
        "violation",
        "month",
        "period",
        "improvement",
        "regulation",
        "end",
        "boehringer",
        "ingelheim",
        "hospira",
        "merck",
        "kgaa",
        "novartis",
        "sanofi",
        "aventis",
        "smithkline",
        "beecham",
        "number",
        "year",
        "till",
        "mumbai",
        "baby",
        "bathwater",
        "cut",
        "article",
        "master",
        "marketing",
        "credibility",
        "manufacturer",
        "beating",
        "series",
        "action",
        "graphic",
        "drugmaker",
        "management",
        "monitoring",
        "quality",
        "compliance",
        "md",
        "september",
        "usa",
        "arcolab",
        "facility",
        "bangalore",
        "mylan",
        "inc",
        "july",
        "fda",
        "company",
        "team",
        "waluj",
        "trend",
        "tolerance",
        "attitude",
        "culture",
        "organisation",
        "dg",
        "shah",
        "secretary",
        "general",
        "alliance"
    ],
    "category": [
        "indiahome",
        "indianews"
    ]
}